Nakano Naoki, Volpin Andrea, Bartlett Jonathan, Khanduja Vikas
Department of Trauma and Orthopaedics, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Indian J Orthop. 2017 Jul-Aug;51(4):414-420. doi: 10.4103/ortho.IJOrtho_230_17.
Despite the initial promise of metal-on-metal (MoM) implants as the ideal bearing surface for hip replacements and resurfacings, high short term failure rates due to an adverse reaction to metal debris (ARMD) have led to a dramatic reduction in the number of MoM implants used in the modern era. With over one million patients worldwide having undergone hip operations utilizing a MoM bearing surface, the long term outcomes for such patients remains unknown, and there is much debate as to the most effective management of these patients. Although several regulatory bodies have released guidelines on the management of patients with MoM hips, these recommendations remain open to interpretation, and the most effective management for these patients remains unclear. The aim of this review is to compare the current guidelines for managing patients with MoM hips and also to discuss established ARMD risk factors, evidence regarding the optimum management for patients with MoM hips, and the indications for revision surgery. Furthermore, although specialized laboratory tests and imaging can be used to facilitate clinical decision making, over-reliance on any single tool should be avoided in the decision making process, and surgeons should carefully consider all findings when determining the most appropriate course of action.
尽管金属对金属(MoM)植入物最初有望成为髋关节置换和表面置换的理想承重面,但由于对金属碎屑的不良反应(ARMD)导致的高短期失败率,使得现代使用的MoM植入物数量大幅减少。全球有超过100万患者接受了使用MoM承重面的髋关节手术,这些患者的长期预后仍然未知,对于这些患者的最有效管理也存在很多争议。尽管一些监管机构已经发布了关于MoM髋关节患者管理的指南,但这些建议仍有待解读,对于这些患者的最有效管理仍不明确。本综述的目的是比较当前管理MoM髋关节患者的指南,并讨论已确定的ARMD风险因素、关于MoM髋关节患者最佳管理的证据以及翻修手术的指征。此外,尽管可以使用专门的实验室检查和影像学来辅助临床决策,但在决策过程中应避免过度依赖任何单一工具,外科医生在确定最合适的行动方案时应仔细考虑所有检查结果。